• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Going alone

anonymous

Guest
Has anyone else heard that our lovely CEO wants to stay as a single entity and not willing to be acquired? Seems though it's not his decision anyway to make.

The concern is we will have to raise again and dilute at some point.
 






























No one knows what's going to happen. So many people are talking about take over take over. I mean we don't know it would be good to get a take over so we can go do something else. Too much crap going on internally. But this is a great prodcut.
 




No one knows what's going to happen. So many people are talking about take over take over. I mean we don't know it would be good to get a take over so we can go do something else. Too much crap going on internally. But this is a great prodcut.
Can you explain this further? Currently interviewing here and not sure what I may be stepping into..
 




Can you explain this further? Currently interviewing here and not sure what I may be stepping into..
They are saying that they don’t want sell but in reality they are just holding out for the best offer. Tarsus is a sinking ship and will need more money soon. It’s really just a matter of time.
Unfortunately, much like Xiidra this sales team will not be needed. Another known entity could just buy the drug and sell off the infrastructure. The best situation for us is to be sold to a company looking to enter the US market. This way they will have a infrastructure, product and US license to do business.
 
















Man if we get taken out i can not see more then $2b valuation. They are going to have to wait to get the stock to run up. Who is going to pay more based on the avg price for the last year..plus 20%? We shall see shortly